Home > AI & Semiconductors Advantest (6857): 2026 Hub Analysis for Semiconductors July 21, 2026June 3, 2026 by DividendDan Advantest (6857): 2026 Hub Analysis for Semiconductors. Fundamentals, valuation, risks, and U.S. investor access.
Home > AI & Semiconductors Keyence (6861): Automation Powerhouse Boosting Dividends July 25, 2026May 13, 2026 by DividendDan Keyence (6861): Automation Powerhouse Boosting Dividends. Fundamentals, valuation, risks, and U.S. investor access.
Home > AI & Semiconductors Hitachi (6501): Lumada, AI and Shareholder Returns July 25, 2026May 8, 2026 by DividendDan Hitachi (6501): Lumada, AI and Shareholder Returns. Fundamentals, valuation, risks, and U.S. investor access.
Home > AI & Semiconductors Disco Corp. (6146): AI Growth and Dividend Analysis July 25, 2026May 7, 2026 by DividendDan Disco Corp. (6146): AI Growth and Dividend Analysis. Fundamentals, valuation, risks, and U.S. investor access.
Home > AI & Semiconductors Fanuc (6954): 2026 Earnings and Dividend Analysis July 25, 2026May 6, 2026 by DividendDan Fanuc (6954): 2026 Earnings and Dividend Analysis. Fundamentals, valuation, risks, and U.S. investor access.
Home > AI & Semiconductors How U.S. Investors Can Buy Shin-Etsu Chemical (4063) July 25, 2026May 1, 2026 by DividendDan How U.S. Investors Can Buy Shin-Etsu Chemical (4063). Fundamentals, valuation, risks, and U.S. investor access.
Home > AI & Semiconductors Harmonic Drive (6324): Robotics Growth and Valuation July 21, 2026February 5, 2026 by DividendDan Harmonic Drive (6324): Robotics Growth and Valuation. Fundamentals, valuation, risks, and U.S. investor access.
Home > AI & Semiconductors Yaskawa (6506): Robotics Growth and Valuation Guide July 21, 2026February 3, 2026 by DividendDan Yaskawa (6506): Robotics Growth and Valuation Guide. Fundamentals, valuation, risks, and U.S. investor access.
Home > AI & Semiconductors Fanuc (6954): Riding the Physical AI Wave in 2026 July 21, 2026January 27, 2026 by DividendDan Fanuc (6954): Riding the Physical AI Wave in 2026. Fundamentals, valuation, risks, and U.S. investor access.
